Incidence of serious infections in the working-age Japanese adult population with rheumatoid arthritis treated with tumor necrosis factor-α inhibitors and interleukin-6 inhibitors: A nationwide retrospective cohort study.
Ryosuke OtaAtsushi HirataTakeo HataMasami NishiharaMasashi NeoTakahiro KatsumataPublished in: Pharmacotherapy (2024)
The results underscore the lack of evidence to preferentially favor either TNFαi or IL-6i as later-line therapy in the management of bDMARDs-naive RA to mitigate the risk of serious infections.